Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations
Open Access
- 24 June 2021
- Vol. 13 (7), 1224
- https://doi.org/10.3390/v13071224
Abstract
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global health problem that the WHO declared a pandemic. COVID-19 has resulted in a worldwide lockdown and threatened to topple the global economy. The mortality of COVID-19 is comparatively low compared with previous SARS outbreaks, but the rate of spread of the disease and its morbidity is alarming. This virus can be transmitted human-to-human through droplets and close contact, and people of all ages are susceptible to this virus. With the advancements in nanotechnology, their remarkable properties, including their ability to amplify signal, can be used for the development of nanobiosensors and nanoimaging techniques that can be used for early-stage detection along with other diagnostic tools. Nano-based protection equipment and disinfecting agents can provide much-needed protection against SARS-CoV-2. Moreover, nanoparticles can serve as a carrier for antigens or as an adjuvant, thereby making way for the development of a new generation of vaccines. The present review elaborates the role of nanotechnology-based tactics used for the detection, diagnosis, protection, and treatment of COVID-19 caused by the SARS-CoV-2 virus.Keywords
This publication has 79 references indexed in Scilit:
- Nanotechnology-based drug delivery systems and herbal medicines: a reviewInternational Journal of Nanomedicine, 2013
- Cellular interactions of therapeutically delivered nanoparticlesExpert Opinion on Drug Delivery, 2011
- Genosensor for SARS Virus Detection Based on Gold Nanostructured Screen‐Printed Carbon ElectrodesElectroanalysis, 2009
- Drug delivery and nanoparticles: Applications and hazardsInternational Journal of Nanomedicine, 2008
- Spontaneous Formation of Functionalized Dendrimer-Stabilized Gold NanoparticlesThe Journal of Physical Chemistry C, 2008
- Exploiting lymphatic transport and complement activation in nanoparticle vaccinesNature Biotechnology, 2007
- A sensitive in vivo model for quantifying interstitial convective transport of injected macromolecules and nanoparticlesJournal of Applied Physiology, 2006
- ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway EpitheliaJournal of Virology, 2005
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Isosteric molecules in non-isomorphous structures: A new route to new structures. The example of 9,10-dihaloanthraceneCrystEngComm, 2004